|
QuintilesIMS Real-World Insights Bibliography
| Direct medical costs of diabetes-related complications in Saudi Arabia |
| Author(s): 1. Hnoosh A
IMS Health, HEOR, London, UK
2. Vega-Hernández G
IMS Health, HEOR, London, UK
3. Jugrin A
IMS Health, HEOR, London, UK
4. Todorova L
Novo Nordisk International Operations, Zürich, Switzerland
|
| Affiliations(s): IMS Health HEOR and Novo Nordisk International Operations, Zurich |
| Publication(s): ISPOR 17th Annual International Meeting, Washington, USA |
| Document Type(s): Conference, Poster |
| Countries: Saudi Arabia |
C:
Y: |
Diabetes
2012 |
|
L:
A: |
English
Literature Review |
|
 |
| |
| |
| Type II diabetes cost of illness study |
| Author(s): S. Babineaux1, W. Fakhoury2, A. McDonell3, R. Kotchie3, M. Ali4. |
| Affiliations(s): 1Eli Lilly and Company, Global Health Outcomes, Indianapolis IN, USA.
2Eli Lilly and Company, Global Health Outcomes, Erl Wood, United Kingdom.
3IMS Health, UK, London, United Kingdom.
4IMS Health, Saudi Arabia, Riyadh, Saudi Arabia.
|
| Publication(s): World Diabetes Congress December 2011, Dubai, UAE |
| Document Type(s): Conference, Poster |
| Countries: Saudi Arabia |
C:
Y: |
Diabetes
2011 |
|
L:
A: |
English
Literature Review |
|
|
| |
| |
| Therapy conversion to biphasic insulin
aspart 30 improves long-term outcomes
and reduces the costs of type 2 diabetes
in Saudi Arabia
|
| Author(s): Mohammed Ali 1 , Jeremy White 2 , Chen-Hui Lee 2 , James L Palmer 3 ,
Jayne Smith-Palmer 3 , Walid Fakhoury 4 , William J Valentine 3
|
| Affiliations(s): 1 IMS Health, Riyadh, Saudi Arabia
2 Novo Nordisk International Operations A/S, Zurich, Switzerland
3 IMS Health, Basel, Switzerland
4 IMS Health, London, UK
|
| Publication(s): Journal of Medical Economics 2008; 11: 651–670 |
| Document Type(s): Abstract |
| Countries: Saudi Arabia |
C:
Y: |
Diabetes
2008 |
|
L:
A: |
English
Cost analysis |
|
|
| |
| |
|
|
|
